Stella Chemifa Corporation (SLO.F)

21.80 -0.60 (-2.68%) As of 08:04AM CEST. Market open.

Stella Chemifa Corporation

Meiji Yasuda Seimei Osaka Midosuji Bldg
10th Floor 4-1-1 Fushimi-machi Chuo-ku
Osaka 541-0044
Japan
81 6 4707 1511
https://www.stella-chemifa.co.jp

Sector(s): Basic Materials
Industry: Specialty Chemicals
Full Time Employees: 727

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Aki Hashimoto	CEO, President & Director	N/A	N/A	1973
Mr. Yasuhiko Nakashima	Executive Officer, GM of Accounting Department & Director	N/A	N/A	1959
Mr. Norio Ogata	Head of Sales Management Department, GM of Osaka Sales Department, Executive Officer & Director	N/A	N/A	1968
Mr. Jun Takano	MD of Research & Development and Director	N/A	N/A	1961
Mr. Kiyonori Saka	Senior MD of Products Management Group & Representative Director	N/A	N/A	1959
Mr. Masaaki Tsuchiya	Executive Officer, Manager of Sanpo Factory & Director	N/A	N/A	1971
Mr. Takeshi Iijima	Executive Officer - Singapore Region & Director	N/A	N/A	1966

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Stella Chemifa Corporation manufactures and sells inorganic fluorine compounds in Japan and internationally. It offers hydrofluoric acid, buffered hydrofluoric acid, and etching solutions used in semiconductors and liquid crystal products; calcium, aluminum, lithium, strontium, barium, magnesium, and lead fluoride used in optical materials; and lithium hexafluorophosphate for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and anhydrous hydrofluoric acid and 55% hydrofluoric acid used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as fluorosilicic acid, potassium fluorosilicate, fluoroboric acid, tin fluoroborate, copper fluoroborate, lead fluoroborate, zinc fluoroborate, sodium fluoroborate, potassium fluoroborate, ammonium hydrogenfluoride, sodium fluoride, potassium fluoride, ammonium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, refined calcium fluoride, and potassium hexafluorophosphate. Further, the company transports a range of special chemical substances, high-pressure gas, hazardous materials, and related products. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.

Corporate Governance

Stella Chemifa Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.